Guardant Health
GH
#1634
Rank
ยฃ9.71 B
Marketcap
ยฃ74.81
Share price
3.55%
Change (1 day)
108.47%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -ยฃ0.31 Billion

According to Guardant Health 's latest financial reports the company's current earnings are ยฃ0.90 Billion. In 2024 the company made an earning of -ยฃ0.32 Billion, an increase over its 2023 earnings that were of -ยฃ0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.31 Billion-5.22%
2024 -ยฃ0.32 Billion-9.12%
2023 -ยฃ0.36 Billion-26.73%
2022 -ยฃ0.48 Billion69.96%
2021 -ยฃ0.29 Billion56.35%
2020 -ยฃ0.19 Billion252.69%
2019 -ยฃ51.22 Million-17.22%
2018 -ยฃ61.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-ยฃ0.46 Billion 55.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ0.23 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA